These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 8564099

  • 1. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma.
    Szczeklik A, Mastalerz L, Nizankowska E, Cmiel A.
    Am J Respir Crit Care Med; 1996 Feb; 153(2):567-71. PubMed ID: 8564099
    [Abstract] [Full Text] [Related]

  • 2. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism.
    Szczeklik A, Dworski R, Mastalerz L, Prokop A, Sheller JR, Nizankowska E, Cmiel A, Oates JA.
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277
    [Abstract] [Full Text] [Related]

  • 3. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M.
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [Abstract] [Full Text] [Related]

  • 4. Effect of inhaled prostaglandin E2 on allergen-induced asthma.
    Pavord ID, Wong CS, Williams J, Tattersfield AE.
    Am Rev Respir Dis; 1993 Jul; 148(1):87-90. PubMed ID: 8317820
    [Abstract] [Full Text] [Related]

  • 5. [Amlexanox has an acute bronchodilator effect in patients with aspirin-induced asthma (AIA)].
    Imokawa S, Satou A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, Chida K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Aug; 31(8):976-82. PubMed ID: 8230896
    [Abstract] [Full Text] [Related]

  • 6. [The influence of misoprostol on post-aspirin bronchoconstriction in patients with aspirin sensitive asthma].
    Szmidt M, Wasiak W.
    Pneumonol Alergol Pol; 1995 Aug; 63(9-10):544-52. PubMed ID: 8620177
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the bronchodilator effect of inhaled furosemide compared to salbutamol in asthmatic patients.
    Rodríguez Vázquez JC, Pino Alfonso PP, Gassiot Nuño C, Paez Prats I, Fernández Manzano E.
    J Investig Allergol Clin Immunol; 1998 Aug; 8(2):115-8. PubMed ID: 9615306
    [Abstract] [Full Text] [Related]

  • 8. The influence of misoprostol (synthetic analogue of prostaglandin E1) on aspirin-induced bronchoconstriction in aspirin-sensitive asthma.
    Szmidt M, Wasiak W.
    J Investig Allergol Clin Immunol; 1996 Aug; 6(2):121-5. PubMed ID: 8727270
    [Abstract] [Full Text] [Related]

  • 9. [Effects of inhaled prostaglandin E1, salbutamol and verapamil on the bronchial reactivity in asthmatics].
    Li ZG.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr; 14(2):101-3, 128. PubMed ID: 1879014
    [Abstract] [Full Text] [Related]

  • 10. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma.
    Sykes AP, Ayres JG.
    Respir Med; 1990 Mar; 84(2):135-8. PubMed ID: 2371435
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bronchodilatory effect of inhaled versus oral salbutamol in bronchial asthma.
    Louridas G, Kakoura M, Galanis N, Patakas D, Kastritsi K.
    Respiration; 1983 Mar; 44(6):439-43. PubMed ID: 6648053
    [Abstract] [Full Text] [Related]

  • 13. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A, Brashier B, Maganji M, Raghupathy A, Mahadik P, Gokhale P, Gogtay J, Salvi S.
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The influence of salmeterol and salbutamol on bronchial constriction in patients with bronchial asthma].
    Tymińska K, Grzelewska-Rzymowska I, Kroczyńska-Bednarek J, Kwiatkowska S.
    Pneumonol Alergol Pol; 1998 Apr; 66(11-12):524-9. PubMed ID: 10391959
    [Abstract] [Full Text] [Related]

  • 17. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.
    Ugeskr Laeger; 1992 Nov 16; 154(47):3325-8. PubMed ID: 1361083
    [Abstract] [Full Text] [Related]

  • 18. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG, Earnshaw JS, Palmer JB.
    Eur Respir J; 1992 Oct 16; 5(9):1062-7. PubMed ID: 1426215
    [Abstract] [Full Text] [Related]

  • 19. Duration of action of inhaled terbutaline at two different doses and of albuterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in asthmatic subjects.
    Malo JL, Ghezzo H, Trudeau C, Cartier A, Morris J.
    Am Rev Respir Dis; 1989 Sep 16; 140(3):817-21. PubMed ID: 2782749
    [Abstract] [Full Text] [Related]

  • 20. Bronchodilator effect of inhaled olprinone, a phosphodiesterase 3 inhibitor, in asthmatic patients.
    Myou S, Fujimura M, Kamio Y, Ishiura Y, Tachibana H, Hirose T, Hashimoto T, Matsuda T.
    Am J Respir Crit Care Med; 1999 Sep 16; 160(3):817-20. PubMed ID: 10471602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.